Table 3. Kaplan-Meier survival analysis and correlations analysis for EMX2OS and EMX2 in pan-cancer (33 types of cancer from TCGA).

Abbreviation	Detail	Log-rank test p-value	Correlation coefficient r	Spearman p-value
ACC	Adrenocortical carcinoma	0.002	0.844	< 0.001
BLCA	Bladder Urothelial Carcinoma	0.083	0.952	< 0.001
BRCA	Breast invasive carcinoma	0.989	0.917	< 0.001
CESC	Cervical squamous cell carcinoma and endocervical adenocarcinoma	0.020	0.954	< 0.001
CHOL	Cholangio carcinoma	0.061	0.311	0.065
COAD	Colon adenocarcinoma	0.783	0.649	< 0.001
DLBC	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	0.744	0.713	< 0.001
ESCA	Esophageal carcinoma	0.872	0.710	< 0.001
GBM	Glioblastoma multiforme	0.226	0.924	< 0.001
HNSC	Head and Neck squamous cell carcinoma	0.498	0.862	< 0.001
KICH	Kidney Chromophobe	0.121	0.792	< 0.001
KIRC	Kidney renal clear cell carcinoma	0.000	0.809	< 0.001
KIRP	Kidney renal papillary cell carcinoma	0.068	0.787	< 0.001
LAML	Acute Myeloid Leukemia	0.762	0.594	< 0.001
LGG	Brain Lower Grade Glioma	0.172	0.919	< 0.001
LIHC	Liver hepatocellular carcinoma	0.979	0.418	< 0.001
LUAD	Lung adenocarcinoma	0.359	0.514	< 0.001
LUSC	Lung squamous cell carcinoma	0.886	0.694	< 0.001
MESO	Mesothelioma	0.838	0.928	< 0.001
OV	Ovarian serous cystadenocarcinoma	0.859	0.799	< 0.001
PAAD	Pancreatic adenocarcinoma	0.634	0.793	< 0.001
PCPG	Pheochromocytoma and Paraganglioma	0.504	0.835	< 0.001
PRAD	Prostate adenocarcinoma	0.382	0.847	< 0.001
READ	Rectum adenocarcinoma	0.829	0.703	< 0.001
SARC	Sarcoma	0.986	0.938	< 0.001
SKCM	Skin Cutaneous Melanoma	0.126	0.896	< 0.001
STAD	Stomach adenocarcinoma	0.002	0.762	< 0.001
TGCT	Testicular Germ Cell Tumors	0.440	0.891	< 0.001
THCA	Thyroid carcinoma	0.356	0.862	< 0.001
THYM	Thymoma	0.141	0.746	< 0.001
UCEC	Uterine Corpus Endometrial Carcinoma	0.677	0.860	< 0.001
UCS	Uterine Carcinosarcoma	0.529	0.908	< 0.001
UVM	Uveal Melanoma	0.013	0.808	< 0.001